Heart attack drug debate: shorter may be safer
NCT ID NCT03252249
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how long people who had a heart attack should take two blood-thinning medicines (aspirin plus a second drug). About 5,000 patients were randomly assigned to shorter or longer treatment. The goal was to find the best balance between preventing another heart attack and avoiding dangerous bleeding. Results help doctors decide the safest treatment length.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Edinburgh Royal Infirmary
Edinburgh, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Ultrasound 'Memory' imaging may reveal hidden heart ischemia
- Can we predict which heart aneurysms will grow?